Skip to main content
Log in

The Number of Metastatic Lymph Nodes is a Significant Risk Factor for Bone Metastasis and Poor Outcome After Surgery for Linitis Plastica-type Gastric Carcinoma

  • Published:
World Journal of Surgery Aims and scope Submit manuscript

Abstract

Background

Linitis plastica-type gastric carcinoma remains a disease with poor prognosis despite an aggressive surgical approach. Although a prominent pattern of disease failure is peritoneal carcinomatosis, some patients experience rapid disease progression without signs of the peritoneal disease.

Methods

Clinicopathologic data from 178 patients with linitis plastica-type gastric cancer operated on between 1991 and 2000 were analyzed. Survival stratified by curability of surgery, pN stage, and patterns of failure were evaluated by using the Kaplan-Meier method, and χ2 test was used to evaluate correlation between the number of metastatic lymph nodes in terms of pN categories and the incidence of various patterns of metastasis and recurrence. Cox regression hazard model was used to identify independent prognostic factors.

Results

R0 resection was performed only among 82 patients (46% of those who underwent laparotomy). Node metastasis was frequent with only 22 patients classified as pN0. Peritoneal carcinomatosis was observed in 131 patients and was the commonest pattern of recurrence. Bone metastasis, found in 13 patients, was associated with poor outcome, and its incidence was significantly correlated with the number of metastatic nodes. pT4 status and pN3 status were identified as significant independent prognostic determinants.

Conclusion

Treatment strategy for the linitis plastica should in general combine surgery with aggressive treatment directed toward peritoneal disease. However, patients with >16 metastatic nodes more often are associated with bone metastasis than those with modest nodal involvement and suffer from poor prognosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Bollschweiler E, Boettcher K, Hoelscher AH et al (1993) Is the prognosis for Japanese and German patients with gastric cancer really different? Cancer 71:2918–2925

    Article  PubMed  CAS  Google Scholar 

  2. Kitamura K, Beppu R, Anai H et al (1995) Clinicopathological study of patients with Borrmann type IV gastric carcinoma. J Surg Oncol 58:112–117

    Article  PubMed  CAS  Google Scholar 

  3. Maruyama K, Okabayashi K, Kinoshita T et al (1987) Progress in gastric cancer surgery in Japan and its limits of radicality. World J Surg 11:418–425

    Article  PubMed  CAS  Google Scholar 

  4. Noguchi Y, Imada T, Matsumoto A et al (1989) Radical surgery for gastric cancer. Cancer 64:2053–2062

    Article  PubMed  CAS  Google Scholar 

  5. Kodera Y, Yamamura Y, Torii A et al (1996) Surgical treatment of Borrmann type IV gastric carcinoma: relevance of lymphadenectomy in improving survival. J Am Coll Surg 183:480–485

    PubMed  CAS  Google Scholar 

  6. Furukawa H, Hiratsuka M, Iwanaga T (1988) A rational technique for surgical operation on Borrmann type 4 gastric carcinoma: left upper abdominal evisceration plus Appleby’s method. Br J Surg 75:116–119

    Article  PubMed  CAS  Google Scholar 

  7. Ota K, Nishi M, Nakajima T (1998) Results of left upper abdominal evisceration (LUAE) for diffuse infiltrating carcinoma of the stomach [in Japanese]. Jpn J Cancer Chemother 15:1249–1255

    Google Scholar 

  8. Otsuji E, Yamaguchi T, Sawai K et al (1999) Regional lymph node metastasis as a predictor of peritoneal carcinomatosis with Borrmann type IV gastric carcinoma. Am J Gastroenterol 94:434–437

    Article  PubMed  CAS  Google Scholar 

  9. Kodera Y, Ito S, Mochizuki Y et al (2007) A phase II study to establish a referential arm for treatment of gastric cancer patients with intraperitoneal micrometastases. Proc Am Soc Clin Oncol 25:18S,15002

    Google Scholar 

  10. Armstrong DK, Bundy B, Wenzel L et al (2006) Intraperitoneal cisplatin and paclitaxel in ovarian cancer. N Engl J Med 354:34–43

    Article  PubMed  CAS  Google Scholar 

  11. Ohashi N, Kodera Y, Nakanishi H et al (2005) Efficacy of intraperitoneal chemotherapy with paclitaxel targeting peritoneal micrometastasis as revealed by GFP-tagged human gastric cancer cell lines in nude mice. Int J Oncol 27:637–644

    PubMed  CAS  Google Scholar 

  12. Kodera Y, Ito Y, Ito S et al (2006) Intraperitoneal paclitaxel: a possible impact of regional delivery for prevention of peritoneal carcinomatosis in patients with gastric carcinoma. Hepatogastroenteorology 54:960–963

    Google Scholar 

  13. Japanese Research Society for Gastric Cancer (1995) Japanese classification of gastric carcinoma. Kanehara Publishers, Tokyo

    Google Scholar 

  14. Sobin LH, Wittekind C (1997) TNM Classification of malignant tumours, 5th edn. Wiley, New York

    Google Scholar 

  15. Maruyama K, Sasako M, Kinoshita T et al (1995) Pancreas-preserving total gastrectomy for proximal gastric cancer. World J Surg 19:532–536

    Article  PubMed  CAS  Google Scholar 

  16. Kodera Y, Ito S, Yamamura Y et al (2004) Detection of disseminated cancer cells in linitis plastica-type gastric carcinoma. Jpn J Clin Oncol 34:525–531

    Article  PubMed  Google Scholar 

  17. Mochiki E, Ohno T, Kamiyama Y et al (2006) Phase I/II study of S–1 combined with paclitaxel in patients with unresectable and/or recurrent advanced gastric cancer. Br J Cancer 95:1642–1647

    Article  PubMed  CAS  Google Scholar 

  18. Nakajo A, Nastugoe S, Hokita S et al (2007) Successful treatment of advanced gastric cancer by surgical resection following combination chemotherapy with oral S-1 and biweekly paclitaxel. Gastric Cancer 10:58–62

    Article  PubMed  Google Scholar 

  19. Glehen O, Mohamed F, Gilly FN (2004) Peritoneal carcinomatosis from digestive tract cancer: new management by cytoreductive surgery and intraperitoneal chemohyperthermia. Lancet Oncol 25:974–978

    Google Scholar 

  20. Glehen O, Schreiber V, Cotte E et al (2004) Cytoreductive surgery and intraperitoneal chemohyperthermia for peritoneal carcinomatosis arising from gastric cancer. Arch Surg 139:20–26

    Article  PubMed  CAS  Google Scholar 

  21. Yonemura Y, Fujimura T, Nishimura G et al (1996) Effects of intraoperative chemohyperthermia in patients with gastric cancer with peritoneal dissemination. Surgery 119:437–444

    Article  PubMed  CAS  Google Scholar 

  22. Nakagawa S, Nashimoto A, Yabusaki H (2007) Role of staging laparoscopy with peritoneal lavage cytology in the treatment of locally advanced gastric cancer. Gastric Cancer 10:29–34

    Article  PubMed  CAS  Google Scholar 

  23. Abdalla EK, Pisters PW (2004) Staging and preoperative evaluation of upper gastrointestinal malignancies. Semin Oncol 31:513–529

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yasuhiro Kodera.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kodera, Y., Ito, S., Mochizuki, Y. et al. The Number of Metastatic Lymph Nodes is a Significant Risk Factor for Bone Metastasis and Poor Outcome After Surgery for Linitis Plastica-type Gastric Carcinoma. World J Surg 32, 2015–2020 (2008). https://doi.org/10.1007/s00268-008-9672-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00268-008-9672-z

Keywords

Navigation